Company Filing History:
1 out of 93 
1 out of 832,912 Years Active: 2015-2017
Title: Innovations by Lawrence Sweetman
Introduction
Lawrence Sweetman is an accomplished inventor based in Heath, Texas. He holds two patents that contribute significantly to the field of cardiac disease research. His work focuses on innovative methods for determining cardiac risk through the analysis of urinary globotriaosylceramide (Gb3) levels.
Latest Patents
One of his latest patents is titled "Urinary triaosylceramide (Gb3) as a marker of cardiac disease." This invention describes a method for determining urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. The determination of Gb3 levels provides a screening method for assessing cardiac risk. It may also offer alternative therapeutic options for managing cardiac disease or mitigating cardiac disease risk by lowering Gb3 levels through the use of pharmacological chaperones or other agents.
Career Highlights
Throughout his career, Lawrence Sweetman has made significant contributions to cardiac research. He has worked with reputable organizations, including the Baylor Research Institute, where he has furthered his research and innovation in the medical field.
Collaborations
Lawrence has collaborated with notable professionals in his field, including Raphael Schiffmann and Fanny Mochel. These collaborations have enhanced his research and contributed to the advancement of cardiac disease management.
Conclusion
Lawrence Sweetman is a notable inventor whose work in cardiac disease research has the potential to impact patient care significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.